CBIS Re-Appoints Mr. Melvin Foote to Its International Government Affairs Board; Mr. Foote Will Continue to Counsel CBIS as South African Cannabinoid Clinical Studies are Underway
24 oct. 2018 08h03 HE
|
Cannabis Science, Inc.
IRVINE, CA, Oct. 24, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
UPDATE: Cannabis Science, Inc. Appoints Dr. Joe Wilson, an Information Technology and Risk Management Expert, to Its International Government Affairs Board (IGAB)
01 oct. 2018 08h12 HE
|
Cannabis Science, Inc.
IRVINE, CA, Oct. 01, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
Cannabis Science, Inc. Appoints Dr. Joe Wilson, an Information Technology and Risk Management Expert, to Its International Government Affairs Board
28 sept. 2018 07h40 HE
|
Cannabis Science, Inc.
IRVINE, CA, Sept. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
Cannabis Science, Inc. Re-Appoints Dr. Brylyne Chitsunge, Pan-African Ambassador for Food Security, and Ms. Julia Royall, Global Health Information Specialist, to Its Revamped Scientific Advisory Board
26 sept. 2018 13h09 HE
|
Cannabis Science, Inc.
IRVINE, CA, Sept. 26, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
Cannabis Science, Inc. Appoints Dr. Jermane Bond, Noted Research Scientist, to Its Scientific Advisory Board
21 sept. 2018 08h23 HE
|
Cannabis Science, Inc.
IRVINE, CA, Sept. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
Cannabis Science Launches New Corporate Advisory Structure; Appoints Presidents for Its Scientific Advisory and International Government Affairs Advisory Boards
12 sept. 2018 08h13 HE
|
Cannabis Science, Inc.
IRVINE, CA, Sept. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
Crown Baus Launches iCannabinoid Marketplace for Cannabis Science; Live Negotiating Platform to Revolutionize How the Medical Cannabis Industry Buys and Sells Equipment and Supplies
07 sept. 2018 12h46 HE
|
Crown Baus Capital Corp.
Beverly Hills, CA, Sept. 07, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Crown Baus Capital Corporation (OTC: CBCA), a global acquisition-based conglomerate with investments primarily in five...
Cannabis Science Invited to Deliver Keynote Address at European Summit Organized by The University of Heidelberg and Harvard Medical School’s Global Health Catalyst
31 août 2018 12h35 HE
|
Cannabis Science, Inc.
IRVINE, CA, Aug. 31, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
CANNABIS SCIENCE TODAY LAUNCHES ITS NEW CORPORATE WEBSITE
21 août 2018 07h48 HE
|
Cannabis Science, Inc.
IRVINE, CA, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the launch of the...
Cannabis Science, Inc. Announces New Company Website, New Management Team Expansions, & Pushes to Complete Updated Financial Reporting Requirements
13 août 2018 11h53 HE
|
Cannabis Science, Inc.
IRVINE, CA, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce it is in...